Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of GPO-VIR FDC vs Liquid Formulations in Pediatric HIV
NCT00312091Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of stavudine, lamivudine, nevirapine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2006; status: completed.
02
Drugs
stavudinelamivudinenevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00312091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312091.